Skip to Content

We invite you to try out our new beta eCFR site at https://ecfr.federalregister.gov. We’ve made big changes to make the eCFR easier to use. Be sure to leave feedback using the 'Feedback' button on the bottom right of each page!

The Office of the Federal Register will be closed Friday, June 18, 2021, in observance of Juneteenth National Independence Day. We will reopen on Monday, June 21, 2021, at 8:45am.

Notice

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Nonproprietary Naming of Biological Products; Withdrawal

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Withdrawal of notice.

SUMMARY:

This document withdraws a Food and Drug Administration (FDA) notice that published in the Federal Register of June 2, 2016 (81 FR 35367).

DATES:

This notice is withdrawn on June 22, 2016.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Howard Muller, Center for Drug Evaluation and Research (CDER), 10903 New Hampshire Ave., Bldg. 51, Rm. 6234, Silver Spring, MD 20993-0002, 301-796-3474.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

FDA published a notice in the Federal Register of June 2, 2016, informing interested parties that the proposed collection of information entitled “Guidance for Industry on Nonproprietary Naming of Biological Products” had been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 and inviting the public to submit comments on the proposed collection to OMB. FDA is withdrawing the proposed collection of information that published on June 2, 2016, at this time.

Start Signature

Dated: June 16, 2016.

Leslie Kux,

Associate Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 2016-14722 Filed 6-21-16; 8:45 am]

BILLING CODE 4164-01-P